Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Average Rating of “Reduce” by Brokerages
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned a consensus rating of “Reduce” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and six have given a hold rating to the company. The average 12 month target price among […]
More Stories
StockNews.com Initiates Coverage on Martin Midstream Partners (NASDAQ:MMLP)
Analysts at StockNews.com started coverage on shares of Martin Midstream Partners (NASDAQ:MMLP – Get Free Report) in a research report...
LandBridge (NYSE:LB) Earns “Buy” Rating from The Goldman Sachs Group
LandBridge (NYSE:LB – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at The Goldman Sachs Group in...
First Majestic Silver (NYSE:AG) & i-80 Gold (NYSE:IAUX) Head to Head Survey
i-80 Gold (NYSE:IAUX – Get Free Report) and First Majestic Silver (NYSE:AG – Get Free Report) are both small-cap basic...
Financial Comparison: Cheniere Energy Partners (NYSE:CQP) vs. Excelerate Energy (NYSE:EE)
Excelerate Energy (NYSE:EE – Get Free Report) and Cheniere Energy Partners (NYSE:CQP – Get Free Report) are both oils/energy companies,...
Delek US (NYSE:DK) Upgraded at Wolfe Research
Delek US (NYSE:DK – Get Free Report) was upgraded by analysts at Wolfe Research from an “underperform” rating to a...
InnSuites Hospitality Trust (NYSE:IHT) Coverage Initiated at StockNews.com
Analysts at StockNews.com began coverage on shares of InnSuites Hospitality Trust (NYSE:IHT – Get Free Report) in a report issued...